Ribozyme-mediated revision of RNA and DNA

Journal of Clinical Investigation

Volumn 112, Issue 3, 2003, Pages 312-318

  Long, Meredith B ^a   Jones III, J P ^a   Sullenger, Bruce A ^a   Byun, Jonghoe ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; RIBOZYME; RNA;

CCR5 GENE; GENE; GENE DISRUPTION; GENE INSERTION; GENE THERAPY; INTRON; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RNA SEQUENCE; RNA SPLICING; STRUCTURAL GENE; ANIMAL; BIOLOGICAL MODEL; DNA REPAIR; ESCHERICHIA COLI; GENETICS; HUMAN; METABOLISM; METHODOLOGY; MUTATION;

ANIMALS; DNA; DNA REPAIR; ESCHERICHIA COLI; GENE THERAPY; HUMANS; INTRONS; MODELS, BIOLOGICAL; MUTATION; RNA; RNA SPLICING; RNA, CATALYTIC;

EID: 0042388176     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200319386     Document Type: Review

References (27)

1. Cech, T.R. 1993. Structure and mechanism of the large catalytic RNAs: Group I and group II introns and ribonuclease P. In The RNA World. R.F. Gesteland and J.F. Atkins, editors. Cold Spring Harbor Laboratory Press. Cold Spring Harbor, New York, USA. 239-269.
2. Sullenger, B.A., and Cech, T.R. 1994. Ribozyme-mediated repair of defective mRNA by targeted trans-splicing. Nature. 371:619-622.
3. Puttaraju, M., Jamison, S.F., Mansfield, S.G., Garcia-Blanco, M.A., and Mitchell, L.G. 1999. Spliceosome-mediated RNA trans-splicing as a tool for gene therapy. Nat. Biotech 17:246-252.
4. Garcia-Blanco, M. 2003. Messenger RNA reprogramming by spliceosome mediated RNA trans-splicing. J. Clin. Invest. In press.
5. Guo, H., et al. 2000. Group II introns designed to insert into therapeutically relevant DNA target sites in human cells. Science. 289:452-457.
6. Mohr, G., Smith, D., Belfort, M., and Lambowitz, A.M. 2000. Rules for DNA target-site recognition by a lactococcal group II intron enable retargeting of the intron to specific DNA sequences. Genes Dev. 14:559-573.
7. Jones, J.T., Lee, S.-W., and Sullenger, B.A. 1996. Tagging ribozyme reaction sites to follow trans-splicing in mammalian cells. Nat. Med. 2:643-648.
8. Jones, J.T., and Sullenger, B.A. 1997. Evaluating and enhancing ribozyme reaction efficiency in mammalian cells. Nat. Biotech. 15:902-90S.
9. Phylactou, L.A., Darrah, C., and Wood, M.J.A. 1998. Ribozyme-mediated trans-splicing of a trinucleotide repeat. Nat. Genet. 18:378-381.
10. Lan, N., Howrey, R.P., Lee, S.-W., Smith, C.A., and Sullenger, B.A. 1998. Ribozyme-mediated repair of sickle β-globin mRNA's in erythrocyte precursors. Science. 280:1593-1596.
11. Kohler, U., Ayre, B.G., Goodman, H.M., and Haseloff, J. 1999. Transsplicing ribozymes for targeted gene delivery. J. Mol. Biol. 285:1935-1950.
12. Ayre, B.G., Kohler, U., Goodman, H.M., and Haseloff, J. 1999. Design of highly specific cytotoxins by using trans-splicing ribozymes. Proc. Natl. Acad. Sci. U. S. A. 96:3507-3512.
13. Watanabe, T., and Sullenger, B.A. 2000. Induction of wild-type p53 activity in human cancer cells by ribozymes that repair mutant p53 transcripts. Proc. Natl. Acad. Sci. U. S. A. 97:8490-8494.
14. Rogers, C.S., Vanoye, C.G., Sullenger, B.A., and George, A.L. 2002. Functional repair of a mutant chloride channel using a trans-splicing ribozyme. J. Clin. Invest. 110:1783-1789. doi: 10.1172/JCI2000216481.
15. Ryu, K.-J., Kim, J.-H., and Lee, S.-W. 2003. Ribozyme-mediated selective induction of new gene activity in hepatitis C virus internal ribosome entry site-expressing cells by targeted trans-splicing. Mol. Ther. 7:386-395.
16. Sullenger, B.A. 1995. Colocalizing ribozymes with substrate RNAs to increase their efficacy as gene inhibitors. Appl. Biochem Biotechnol. 54:57-61.
17. Lan, N., et al. 2000. Enhancing RNA repair efficiency by combining trans-splicing ribozymes that recognize different accessible sites on a target RNA. Mol. Ther. 2:245-255.
18. Long, M.B., and Sullenger, B.A. 1999. Evaluating group I intron catalytic efficiency in mammalian cells. Mol. Cell. Biol. 19:6479-6487.
19. Hagen, M., and Cech, T.R. 1999. Self-splicing of the Tetrahymena intron from mRNA in mammalian cells. EMBO J. 18:6491-6500.
20. Zarrinkar, P.P., and Sullenger, B.A. 1998. Probing the interplay between the two steps of group I intron splicing: competition of exogenous guanosine with ω G. Biochemistry. 37:18056-18063.
21. Zarrinkar, P.P., and Sullenger, B.A. 1999. Optimizing the substrate specificity of a group I intron ribozyme. Biochemistry. 38:3426-3432.
22. Curcio, M.J., and Belfort, M. 1996. Retrohoming: cDNA-mediated mobility of group II introns requires a catalytic RNA. Cell. 84:9-12.
23. Cousineau, B., et al. 1998. Retrohoming of a bacterial group II intron: mobility via complete reverse splicing, independent of homologous DNA recombination. Cell. 94:451-462.
24. Matsuura, M., et al. 1997. A bacterial group II intron encoding reverse transcriptase, maturase, and DNA endonuclease activities biochemical demonstration of maturase activity and insertion of new genetic information within the intron. Genes Dev. 11:2910-2924.
25. Wank, H., SanFilippo, J., Singh, R.N., Matsuura, M., and Lambowitz, A.M. 1999. A reverse transcriptase/maturase promotes splicing by binding at its own coding segment in a group II intron RNA. Mol. Cell. 4:239-250.
26. Saldanha, R., et al. 1999. RNA and protein catalysis in group II intron splicing and mobility reactions using purified components. Biochemistry. 38:9069-9083.
27. Jasin, M. 1996. Genetic manipulation of genomes with rare-cutting endonucleases. Trends Genet. 12:224-228.